Absci Corporation stock is up 21.54% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 December’s closed higher than November. 100% of analysts rate it a buy.
Absci Corporation provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci was founded in 2011 and is headquartered in Vancouver, Washington.